Skip to main content

Table 1 Baseline characteristics of included patients

From: Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study

 

Ulcerative Colitis

Number of patients

21

Age (mean, range)

36.8 (19–70)

Female [%]

48

Smoking status [%]

 Never

95

 Current

5

Mayo clinical score (mean, range)

4.1 (1–7)

Adjunctive therapy [%]

 Steroids

42.9

 Immunosuppressants

14.3

Previous exposure to anti-TNF [%]

76

Previous surgery [%]

0

Localization [%]

E1: 19

E2: 24

E3: 57